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Modulation of the expression of the ex.,P3 contplex on 
hUl11an derntal nticrovascular endothelial cells 
(HDMEC) ntay be crucial in wound healing and an-
giogenesis. Therefore, we exantined the influence of 
basic fibroblast growth factor (bFGF), transfornting 
growth facto~ p, and inter~eron-~ (IFN-y) on the ~x­
pression of thIs contplex. Stlntulatlon ofHDMEC wIth 
bFGF increased cell surface expression of both ex., and 
P in a dose- and tinte-dependent ntanner associated 
~ith the developntent of a spindled, elongated cell 
l11orphology. Northern blot analysis ofHDMEC stint-
ulated with bFGF dentonstrated a ntarked increase 
in P3 but not ex., ntRNA expression. Incubation of 
T he formation and regeneration of the cutaneous mi-crovasculature after injury involves both endothelial cel l pro liferation and recruitment of endothelial cells from pre-existing vessels. Matrix molecules such as fibronectin, vitronectin, and fibrino gen potentially 
may serve as scaffolding for endothelial cell migration into injured 
tissue, which is critical in the formation of new vessels. Endothelial 
cell interactions with matrix proteins are mediated via a specific 
family of cell surface adherence proteins known as integrins [1-4] . 
Integrins are expressed on the cell surface as heterodimers with a-
and fJ-subunits and are linked to the cytoskeleton. The integrins 
have been divided into subfamilies, with members of each subfamily 
containing a common fJ-subunit . One such SlIbfamily of integrins is 
referred to as cytoadhesions, and members of this group contain the 
fJ3 integrin chain associated with either the allb or the a,. chain. The 
a"f33 complex has been commonly referred to as the vitronectin 
receptor and is pr~sent on the surface of many type~ of cell s itl v~vo 
and irz vitro [1]. Tl1lS complex has been shown to mediate endothelial 
cell binding to a variety ofligands including vitronectin, fibrinogen, 
von Willebrand factor, thrombospondin, and complexes of pro-
teases, coagulation components, and activated complement proteins 
bound to vitronectin [5 - 10]. 
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HDMEC with transfornting growth factor-p or inter-
feron-y alone resulted in ntodest decreases in cell sur-
face ex.,P3' and co-incubation of HDMEC with bFGF 
and transfornting growth factor-p or interferon-y in-
hibited bFGF-induced changes in cell ntorphology, in-
creases in cell surface ex.,P3 expression, and increases in 
P3 ntRNA. These data dentonstrate that both growth 
factors and pro-inflantntatory cytokines alter the ex-
pression of ex.,P3 on nticrovascular endothelial cells and 
that these alterations correlate with changes in cell 
ntorphology. Key words: endothelial/microvascular/inte-
grin/growthfactor.] Invest Dermatol 103:295-299, 1994 
Endothelial cell morphology and behavior is regulated by a com-
plex interplay between extracellular matrix, endothelial cell adhe-
sion molecules, and the presence or absence of growth fac tors or 
cytokines that may affect either of these components. Protein kinase 
C agonists, such as phorbol 12-myristate 13-aceta te (PMA) , have 
been shown to induce endothelial cell alterations in lIitro that are 
similar to changes observed ill lI illO that are associated with neoan-
giogenesis (11] . These include changes in endothelial cell morphol-
ogy, invasion of collagen gels and the formation of vascular struc-
tures, and the production of matrix proteases. Furthermore, PMA 
stimulation of human derm al microvascular endothelial cells 
(HDMEC) has been shown to induce profound changes in 
HDMEC morphology, and these changes are accompanied by in-
creaseS in cell surface a y P3 expression [1 2]. 
The morphology of endothelial cells, their migration on matrix, 
their invasion of coHagen gels, and their expression of matrix de-
grading proteases has previously been shown to be modulated by 
growth factors such as bas ic fibrobl as t growth factor (bFGF) and 
transforming growth factor-fJ (TGF-fJ) [13 - 15]. Like PMA, bFGF 
has been shown to m ediate some of its effects via stimulation of 
protein kinase C [16] . Because of these observations, it seemed likely 
that bFGF mi ght also alter cell surface integrin expression. Similar 
studies have examined the regulation of integrins by growth factors 
and inflammatory cytokines and found that these solubl e factors can 
alter cell surface integrin expression [1 7 -19]. However, th e regula-
tion of integrin expression on endothelial ceHs, particularly micro-
vascular endothelial cells , has not been extensively examined [20]. 
W e therefore examined the effects ofbFGF alone or in combination 
with TGF-fJ and IFN-y, on a y fJ3 integrin cell surface and mRNA 
expression on HDMEC and correlated these effects with changes in 
cell morphology . Our da ta indica te that growth factors and cyto-
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kines alter the expression of the (XvP3 complex on microvascular 
endothelial cells and that these alterations correlate with changes in 
cell morphology . 
MATERIALS AND METHODS 
Isolation and Culture of Human Dermal Microvascular Endothelial 
Cells Human dermal microvascular endothelial cells were iso lated from 
human foreskins by a previously described technique [21] . Cells were cul-
tured in media consisting ofMCDB 131 (Clonetics Corp., San Diego, CAl, 
30% normal human serum (Irvine Scientific, Irvine, CAl, epidermal growth 
factor (5 ng/ml, C lonetics), hydrocortisone acetate (1 Ilg/ml, Sigma), dibu-
tyryl cyclic adenosine monophosphate (5 X 10- 5 M, Sigma), 100 U/ml 
penicillin (Sigma), 100 Ilg/ml streptomyclll (Sigma) , 10 Ilg/ml clprofloxa-
cillin (Miles Pharmaceuticals, West Haven, CT), and 250 Ilg/ml amphoter-
icin B (Sigma). 
Antibodies and Cytokines Hybridomas producing monoclonal anti-
body (MoAb) 3F12, which recognizes the (Xv integrin chain, were obtained 
from Dr. Eric Brown (Washington University, St. Louis, MO) [22]. MoAb 
AP-3, which recognizes a cell surface epitope on the P3 integrin, was ob-
tained from Dr. Peter Newman (Milwaukee Blood Institute, Milwaukee, 
WI) and was provided as ascites. Recombinant human bFGF was obtained 
from Dr. David Carmicheal (Synergen, Boulder, CO). Human TGF-p was 
purchased from R&D Systems (Minneapolis, MN). PMA was obtained from 
Sigma. Interferon-y (IFN-y) was obtained from Genentech Inc. (South San 
Francisco, C Al . 
Enzyme-Linked Immunosorbent Assay (ELISA) Expression of cell 
surface integrin chains was measured by ELISA as previously described [21]. 
Cel ls were stimulated with bFGF (10 ng/ml to 1 J.lg/ml); TGF-p (1 ng/ml) 
alone or together with bFGF (1 Ilg/ ml); IFN-y (1000 U/ml) alone or to-
gether with bFGF (1 Ilg/ml); PMA (100 ng/ml) alone or together with 
TGF-p (1 ng/ml) or IFN-y (1000 U / ml), and incubated for 1 to 72 h. 
Expression of cell surface a. or P3 expression was examined as previously 
described [21] . Values in each figure represent the mean of four data points 
from a single representative experiment ± SD and statistical significance 
was assessed using a non-paired t test . 
Flow-Cytometric Analysis HDMEC w ere stimulated as described 
above, probed with MoAb recognizing the (Xv or P3 integrin subunits, and 
examined by flow cytometry as described previously [12,21]. Mean channel 
and fluorescence was determined for each data point using a minimum of 
5000 events. 
Isolation of Total Cellular RNA for Northern Blot Analysis Total 
ce llular RNA was isolated from experimental cells by guanidinium isothio-
cyanate lysis and CsCL density gradient pelleting [23,24]' Equal quantities 
of RNA samples (10 J.lg) were fractionated over formaldehyde/agarose gels, 
transferred to Nytran (Schleicher & Schull, Keene , NH) nylon membranes, 
and then ultraviolet cross-linked to membranes using an automated ultravi-
olet exposure device (Stratagene, La Jolla, C Al. Membranes were first pre-
hybridized, then hybridized overnight at 42 °C with 20 ng of randomly 
primed 32P-labcled cDNA fragments for the a v and the /33 chain (both Telios 
Pharmaceuticals, San Diego, CA) (specific activities 108 to 109 cpm/Ilg). 
Probed membranes were washed and exposed to XAR-2 film with one 
intensifying screen at -70°C. Following hybridization with specific cDNA 
probes, membranes were stripped and rehybridized with a p-actin cDNA 
fragment to assess uniformity of RNA loading and transfer. Two-dimen-
sional autoradiographic densitometry with background subtraction was per-
formed utilizing a LaCie 1200 dpi color scanner interfaced with a MacIntosh 
IIcx and was analyzed with NIH Image software (version 1.35) . 
RESULTS 
Morphology of HDMEC Unstimulated cultures of HDMEC 
displayed the typical, regular, characteristic cobblestone morpho l-
ogy of endothelial cells (Fig 1a). Stimulation of HDMEC by bFGF 
resulted in changes in endothelial cell morphology. Endothelial 
cells became more elongated and spindle shaped. Morphologic 
changes were clearly evident with treatment with 100 ng/ml of 
bFGF and became more pronounced with doses of 1 Ilg/ml. The 
bFGF-induced morphologic changes were first observed after 24 h 
of stimulation and maximal changes were seen after 72 h (Fig 1b). 
The shape changes in HDMEC induced by bFGF were comparable 
to the changes in cell shape previously observed after stimulation of 
HDMEC with the protein kinase C agonist PMA (Fig lc) . 
TGF-p or IFN-y alone did not result in marked changes in 
HDMEC morphology. However, stimulation of HDMEC with 
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Figure 1. HDMEC morphology is influenced by bFGF, PMA, TGF-
p, and IPN-y. a) Unstimulated HDMEC. HDMEC stimulated with (b) 
bFGF (1 J.lg/ml X 72 h), (e) PMA (100 ng/ml X 72 h), (d) TGF-fJ (1 ng/ 
ml X 72 h), and bFGF (e) IFN-y (1000 U / ml X 72 h) and bFGF.J) TGF-fJ 
(1 ng X 72 h) and PMA (100 ng/ml X 72 h). Bar, 100 J.lm. 
TGF-p (1 ng/ml) or IFN-y (1000 U/ml) inhibited bFGF-induced 
changes in cell shape, even when bFGF was used in maximal doses 
of 1 flg/ml (Fig ld, e) . In contrast, the morphologic changes in-
duced by PMA were not blocked by TGF-p (Fig 1f) or IFN-y (data 
not shown). 
Cell Surface Expression of the ex.P3 COInplex on HDMEC 
Examination of cell surface expression of (Xv and P3 by ELISA dem-
onstrated that stimulation with bFGF resulted in a dose- (Fig 2a) 
and time- (Fig 2b) dependent increase of up to 100% of both inte-
grin chains. Increases in expression were evident at doses ofbFGF as 
low as 10 ng/ml and maximal increases were observed with doses 
up to 1 flg/ml. The increases in (XvP3 expression were also induced 
by bFGF in endothelial basal media without EGF, hydrocortisone, 
or cyclic adenosine monophosphate (data not shown) . 
Because bFGF may augment cell proliferation and apparent in-
creases in cell surface protein expression as measured by ELISA 
could be due to increased cell number, we examined the cell surface 
expression of the frv and fJ3 integrin chains on HDMEC by flow 
cytometry. Comparable increases in the expression of both (Xv and Pl 
as determ.ined by mean channel fluorescence were observed in 
bFGF-stimulated HDMEC (Fig 2c) . The increases in cell surface of 
ex. and P3 on HDMEC coincided with the onset of morphologic 
changes. Increases in cell surface expression were observed as early 
as 24 h and became most pronounced after 72 h. 
Because the ex. integrin chain may associate with anyone of 
multiple beta chains, we focused our subsequent studies of cell sur-
face expression on the P3 integrin chain, which only complexes 
with frv on nucleated cells examined to date [2]. Therefore, alter-
ations in the expression of P3 integrin chain reflect changes in the frvP3 complex. Incubation of HDMEC with TGF-p resulted in a 
30 - 50% decrease in P3 expression when examined by ELISA or 
flow-cytom etric analysis (data not shown). IFN-y also induced a 
modest decrease in P3 expression after 72 h (data not shown). In 
addition, incubation of HDMEC with either TGF-p or IFN-y in· 
hibited bFGF-induced upregul ation of P3 ex pression between 50 
and 100% after 72 h (Fig 3), correlating with TGF-p inhibition of 
bFGF induced morphologic changes (Fig 1, see above). 
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Figure 2. bFGF increases HDMEC cell surface expression of cx./1l. Examination by ELISA. a) Dose response: 1-I0MEC were stimulated with doses of 
bFGF from 10 ng/ml to 1 ,ug/ml for 72 h and evaluated for cell surface expression by ELISA. b) Time course: HDMEC were stimulated with 1 ,ug/ ml ofbFGF 
1 to 72 h and eva~uated fo.r cell surface expression by ELISA (values represent the mean of fouf values from a representative experiment ± SO, ' p < 0.05). 
c) Flow-cytometnc anal ysIs: HOMEC were sttmulated wIth bFGF (1 pg/ml X 72 h) and expreSSIOn of 0'. and /1, was detec ted by flow-cytometric analysis. 
Mean channel fluorescence mcreased from 15 to 34.5 for HOMEC stamed for 0'. expressIon (top) and from 7.1 to 19 for fJ, expressIon (bottom). T he increases 
seen in this experiment were somewhat greater than seen on average. The average increase in a. expression was 64% (n = 6) whereas the average increase in/1J 
was 68% (n = 5). 
N orthern Blot Analysis of ll'v and /13 mRNA Stimulation of 
HDMEC with bFGF resulted in an increase in the expression of /13 
rnRNA, which was first detected after 16 h of stimulation. M axi-
mum increases of /13 mRNA (up to tenfold) were seen after 48 h of 
bFGF treatment and increased mRNA levels persisted, although 
slightly decreased fro m maximal levels, after 72 h (Fig 4). How-
ever, expression of o'v mRNA was not altered by treatment of 
HDMEC with bFGF. N orthern blots demonstrating the marked 
incr eases in/13 mRNA induced by bFGF were stripped and reprobed 
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Figure 3. TGF-/1 and IFN-y inhibit bFGF-induced increases in 
HDMEC /1,. HDMEC were stimulated with bFGF (1 ,ug/ ml X 72 h) , 
bFGF (1 pg/ml X 72 11) and TGF-/1 (1 ng/ ml) , and bFGF (1 Jtg/ml X 72 h) 
and IFN-y (1 000 U / ml X 72 h) and ce ll surface expression of /1, was assessed 
by ELISA (values represent the mean of four values from a representative 
experiment ± SO, 'p < 0.05) . 
for a. mRNA expression and no increases were seen after 4 16 24 
48, or 72 h of stimulation (Fig 4). ' , , 
Examination of HDMEC co-stimulated with bFGF and TGF-/1 
at 48 h demonstrated a 70% inhibition of the bFGF-induced upreg-
ulation of /13 mRNA (Fig 5). Additionally, bFGF induced increases 
in /13 mRNA were compl etely abrogated by co-incubation with 
IFN-y (Fig 6). We previously demonstrated that PMA stimu lation 
of HDMEC induced increases in cel l surface /13 expression [12]. 
However TGF-fJ (data not show n) and IFN-y (Fig 6) did not inhibit 
increases of /13 mRNA induced by PMA. T hese observations arc 
consistent with the fact that TGF-/1 and IFN-)I did not inhibit 
PMA-mediated changes in cell morphology (Fig 1, see above) and, 
in addition, neither TGF-/1 nor IFN-y inhibited the upregulation of 
either /13 cell surface or mRNA expression induced by PMA (data 
not shown). 
Discussion E ndothelial cells (EC) are normall y adherent to a 
complex basement membrane consisting of type IV collagen, la-
c 4 16 24 48 72 
J33 
KTlN 
Figure 4. bFGF increases /1, but not a. mRNA in HDMEC. Total 
cellular RNA was extracted from unstimulated, or 1-1 0 MEC stimulated with 
bFGF (1 Jtg/ ml) for times ranging from 4 to 72 It and Northern blots 
performed as described in Materials alld Methods. 
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Figure 5. TGF P inhibits bFGF-induced increases in Pl mRNA. Total 
cellular RNA was extracted from unstimulated (A), or HDMEC stimulated 
with TGF-p (1 ng/ml X 48 h) (B), bFGF (1 ,ug/ml X 48 h) (C), bFGF 
(1 ,ug/ml X 48 h) and TGF-p (1 ng/ml 48 h) (D), and Northern blots per-
formed as described in Materials aud Methods. 
minin, and fibronectin. During neoangiogenesis, which may ac-
company wound healing or inflammation, microvascular endothe-
lial cells must attach to and migrate through a transiently formed 
meshwork of interstitial matrix proteins that may include deposited 
serum proteins such as vitronectin, fibrinogen, or thrombin. Be-
cause integrins are molecules that link extracellular matrix with the 
cytoskeleton of the cell, they appeared to be likely candidates for 
cell surface proteins, which may play an important role in the medi-
ation of changes in endothelial cell shape and behavior. Further-
more, agents that stimulate angiogenesis are also likely to alter the 
expression of endothelial cell integrins. 
bFGF is a potent angiogenic factor in vivo and ill vitro. Previous 
studies have shown that bFGF has effects on endothelial cell shape, 
motility, and protease secretion, all of which are likely to playa role 
in vascular remodeling [13 -15]. In this study, we demonstrated that 
HDMEC stimulated with bFGF in culture developed marked 
changes in cell morphology similar to those previously observed 
with bovine endothelial cells [16], although the dose of bFGF re-
quired to induce morphologic changes was significantly greater 
than what has been previously reported. The bFGF-induced mor-
phologic changes clearly correlated with increases in cell surface (XJl3 expression. The doses of bFGF required to induce maximal 
shape changes paralleled those required to induce maximal increases 
in (XvP3 expression and agents with inhibited bFGF-induced in-
creases in cx.P3 also prevented the expression of altered cell shape. 
Stimulation of HDMEC with bFGF demonstrated that changes 
in cell surface ex. expression were always associated with comparable 
changes in P3 expression. However, these changes were not re-
flected on the mRNA level. bFGF induced marked increases of P3 
mRNA expression whereas ex. mRNA levels remained unchanged . 
These observations are in contrast to those seen after PMA stimula-
tion ofHDMEC [12], where PMA increased expression of both ex. 
and /33 mRNA. These data suggest that the quantity of cx./33 ex-
pressed on the surface of HDMEC may be regulated via transcrip-
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tional and the translational control, and also perhaps via changes in 
protein trafficking. Previous studies have described changes in the 
expression of the (XvP3 complex on HUVEC without parallel 
changes in mRNA. These studies found stimulation of HUVEC 
with TNF and IFN-y resulted in decreased cell surface expression 
without affecting either (Xv or P3 mRNA expression [17]. Similarly, 
increases in (XvP3 expression in HDMEC after bFGF stimulation 
may be the result of increased transcription of the P3 gene coupled 
with increased translation of pre-existing (Xv mRNA. 
TGF-p alone has also been shown to augment the expression of 
integrin complexes on a variety of cultured cells [18,19]. TGF-p has 
also been shown to inhibit bFGF-induced increases in endothelial 
cell migration and plasminogen activator secretion [13,25]. Because 
of these previously reported interactions, we examined the effect of 
TGF-p on bFGF-induced morphologic shape changes on (XvP3 pro-
tein and gene expression in HDMEC. We found that changes in 
HDMEC morphology as well as changes in cell surface cx.P3 and P3 
mRNA expression induced by bFGF were blocked almost com-
pletely by TGF-/3. These data suggest that TGF-p inhibition of 
bFGF effects on endothelial cells may occur not only at the level of 
protease activity, but also via modulation of cell surface cx.P3' Eke 
TGF-p, IFN-y also antagonized bFGF-induced alterations in 
HDMEC morphology and completely inhibited bFGF-induced in-
creases in cell surface (XvP3 and P3 mRNA expression. This is in 
contrast to previous studies on umbilical vein endothelial cells, 
which demonstrated that only prolonged stimulation with both 
TNF-(X and IFN-y downregulated cell surface expression of the 
cx.P3 [17] . 
Platelets, inflammatory cell s such as monocytes or lymphocytes, 
or tumor cells such as melanoma cells [26,27] may serve as a source 
of growth factors that may induce endothelial cell proliferation, 
migration, and angiogenesis . These cells may also serve as a source 
of other factors, such as TGF-p and IFN-y, which may act to modu-
late neovascularization by inhibiting bFGF activity. The doses of 
bFGF required to induce morphologic changes and increases in cell 
surface expression of cx.P3 were clearly greater than doses previously 
reported to induce proliferation of endothelial cells [28]. However, 
it should be noted th at previous studies have clearly shown that 
non-proliferative responses to FGF such as chemotaxis [28] and 
collagen production [29] by endothelial cell s often require 10 - 100-
fold higher concentrations than those observed for proliferation. 
These responses include induction of human microvascular endo-
a 
Ethidium 
bromide 
b 
i i 
Figure 6. IFN Y inhibits bFGF-induced increases of Pl mRNA in 
HDMEC. Total cellular RNA was extracted from unstimulated HDMEe , 
or HDMEC stimulated with IFN-y (1000 U /ml X 48 hours), bFGF (1 ,u 
ml X 48 h), PMA (100 ng/ml X 72 h), IFN-y (1000 U/ml X 48 h) and 
bFGF (1 ,ug/tnl X 48 h) , and IFN-y (1000 Vl ml X 48 h) and PMA 
(100 ng/ml X 48 h) . Northern blots were performed as described in Materi-
als and Methods. a) P3 mRNA. b) Ethidium bromide staining of the gel 
demonstrated equal loading of total RNA. 
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thelial cell migration (250 ng/ml [30]' 100 ng/ml [28]) and inva-
sion of human amnion (70 ng/ml [31]) . Furthermore, even th ese 
doses did not clearly induce maximal responses in these studies. 
The significance of these observations in physiologic and patho-
logic conditions is potentially very important. Endothelial cells in 
injured tissues or adjacent to proliferating tumor cells are called 
upon to proliferate and migrate to form new blood vessels. Micro-
vascular endothelial cells are more likely than large vessel endothe-
lial cells to participate in neovascularization that accompanies these 
events. The response of cultured microvascular endothelial cells to 
growth factors and cy~okines is consistent ~ith this role. The ~e­
havior of cultured microvascular endothe lial cells treated with 
bFGF clearly parallels changes in endothelial cells observed in re-
generating tissue. It is therefore reasonable that growth factors that 
playa critical role in facilitating neovascularization would induce 
changes in cell surface expression of proteins that playa central role 
in cell-matrix interactions. In particular, it is not surprising that the 
a"P3 complex, which is critical for a variety of interactions with the 
proteins comprising wound matrix, is augmented by bFGF treat-
ment and can be modulated by the cytokines known to be principal 
participants in wound healing, TGF-/3 and INF-y. 
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